Long-Term Persistence of Hormonal Adaptations to Weight Loss
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Background After weight loss, changes in the circulating levels of several peripheral hormones involved in the homeostatic regulation of body weight occur. Whether these changes are transient or persist over time may be important for an understanding of the reasons behind the high rate of weight regain after diet-induced weight loss. Methods We enrolled 50 overweight or obese patients without diabetes in a 10-week weight-loss program for which a very-low-energy diet was prescribed. At baseline (before weight loss), at 10 weeks (after program completion), and at 62 weeks, we examined circulating levels of leptin, ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide 1, amylin, pancreatic polypeptide, cholecystokinin, and insulin and subjective ratings of appetite. Results Weight loss (mean [±SE], 13.5±0.5 kg) led to significant reductions in levels of leptin, peptide YY, cholecystokinin, insulin (P Conclusions One year after initial weight reduction, levels of the circulating mediators of appetite that encourage weight regain after diet-induced weight loss do not revert to the levels recorded before weight loss. Long-term strategies to counteract this change may be needed to prevent obesity relapse. (Funded by the National Health and Medical Research Council and others; ClinicalTrials.gov number, NCT00870259.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hormonal and metabolic changes induced by weight reduction result in elevated appetite and reduced metabolic rate [13][14][15].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [13]
In the citing paper
“Weight loss is accompanied by persistent endocrine adaptations30 that increase appetite and decrease satiety31 thereby resisting continued weight loss and conspiring against long-term weight maintenance.”
From Maintenance of Lost Weight and Long-Term Management of Obesity (2018) · cites this paper as [30]
In the citing paper
“studies have shown that the pandemic was associated with weight gain in the general population. 25”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [25]
In the citing paper
“and to increased appetite. 9-11”
From Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined (2021) · cites this paper as [10]
In the citing paper
“although only 2% of eligible patients are currently receiving therapy [17].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [17]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., & Purnell, J. Q. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012908 · Cited by 2,241
Changes in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012
Cited by
Items 601–700 of 1,004
The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight
Melvin, A., le Roux, C. W., & Docherty, N. G. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0599-9 · Cited by 25
Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon
Baumard, L., Weerts, Z. Z. R. M., Masclee, A., Keszthelyi, D., Michael-Titus, A. T., & Peiris, M. (2021) · Nutrients · doi:10.3390/nu13041271 · Cited by 22
“least 12 months, despite weight loss [53].”
Physical Activity, Obesity and Weight Loss Maintenance
Brandt, C., & Pedersen, B. K. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_575 · Cited by 23
Effects and possible mechanisms of intermittent fasting on health and disease: a narrative review
Li, Z., Huang, L., Luo, Y., Yu, B., & Tian, G. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad026 · Cited by 22
Why are we still in need for novel anti-obesity medications?
Novikoff, A., Grandl, G., Liu, X., & Müller, T. D. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101098 · Cited by 22
“31 The apparent success of semaglutide dose-tapering raises the possibility that gradual cessation of AOMs, or diets, could facilitate a more gradual hormonal adjustment to fi t a new body weight set point, thereby reducing the risk of rapid weight regain potentially inherent to abrupt…”
Šestan-Peša, M., & Horváth, T. L. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.12.003 · Cited by 22
Gavrieli, A., & Mantzoros, C. S. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.3.361 · Cited by 22
Campos, J. M., RAMOS, A. C., SZEGO, T., Zilberstein, B., Neto, H. F. E. C., & COHEN, R. V. (2016) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-6720201600s10025 · Cited by 25
Menguer, R. K., Weston, A. C., & Schmid, H. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2547-3 · Cited by 25
Liu, M., Zhang, Z., Zhou, C., He, P., Zhang, Y., Li, H., Li, Q., Liu, C., Wang, B., Li, J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa823 · Cited by 23
Burch, K. E., McCracken, K., Buck, D. J., Davis, R. L., Sloan, D. K., & Curtis, K. S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.800266 · Cited by 23
Hankir, M. K., Bronisch, F., Hintschich, C. A., Krügel, U., Seyfried, F., & Fenske, W. K. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.010 · Cited by 24
Diet-induced thermogenesis in postoperatve Roux-en-Y gastric bypass patients with weight regain
Cardeal, M. D. A., Faria, S. L., Faria, O. P., Facundes, M., & Ito, M. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.01.019 · Cited by 22
“related to early weight losing period (2, 6, 21) .”
BackgroundDowla, S. A., Pendergrass, M., Bolding, M., Gower, B. A., Fontaine, K. R., Ashraf, A. P., Soleymani, T., Morrison, S. A., & Goss, A. M. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.03.014 · Cited by 23
Jin, Z., Li, J., Thackray, A. E., Shen, T., Deighton, K., King, J. A., & Stensel, D. J. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01726-4 · Cited by 20
Gokulakrishnan, K., Ranjani, H., Weber, M. B., Pandey, G. K., Anjana, R. M., Balasubramanyam, M., Prabhakaran, D., Tandon, N., Narayan, K. M. V., & Mohan, V. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1015-9 · Cited by 23
Game changers: do new medications make lifestyle‐based treatment of obesity obsolete?
Lewis, K. H., Moore, J. B., & Ard, J. D. (2023) · Obesity · doi:10.1002/oby.23962 · Cited by 20
“In the setting of energy restriction and weight loss, the body mounts counterregulatory physiologic cues that persist well into the weight-maintenance phase [2 – 4].”
BackgroundFinan, B., Douros, J. D., Goldwater, R., Hansen, A. M. K., Hjerpsted, J., Hjøllund, K. R., Kankam, M. K., Knerr, P. J., Konkar, A. A., Mowery, S. A., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102129 · Cited by 21
“Although intensive lifestyle modi fi cation through diet and exercise is an important early intervention, it is usually insuf fi cient to reverse disease progression [2].”
Scott, R., Tan, T., & Bloom, S. R. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00007-9 · Cited by 21
“The levels of many satiating hormones decline with weight loss, including amylin and PP (Sumithran et al., 2011), while orexigenic NPY and ghrelin, plus its activating enzyme GOAT, in- crease after weight loss (Hansen et al., 2002; Reimer, Maurer, Lau, & Auer, 2010; Sumithran et al., 2011; Yu,…”
BackgroundBatterham, M. J., Tapsell, L. C., & Charlton, K. E. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.45 · Cited by 20
Cheung, A. S., Tinson, A. J., Milevski, S. V., Hoermann, R., Zajac, J. D., & Grossmann, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0117 · Cited by 21
Morin, I., Bégin, C., Maltais‐Giguère, J., Bédard, A., Tchernof, A., & Lemieux, S. (2018) · Journal of Obesity · doi:10.1155/2018/4259389 · Cited by 24
“In response to the state of energy imbalance, body fat stores are gradually depleted and many hormonal signals are secreted to promote appetite in order to increase energy intake and replenish body fat stores [6].”
InfluentialIntermittent Fasting: A User-Friendly Method for Type 2 Diabetes Mellitus
Saeed, M., Ali, M. B. H., Zehra, T., Zaidi, S. A. H., & Tariq, R. (2021) · Cureus · doi:10.7759/cureus.19348 · Cited by 24
“Bariatric surgery is an effective strategy to manage obesity; however, it is limited by its accessibility, potential for complications, and invasive nature [15].”
BackgroundThe Maintenance of Energy Balance Is Compromised after Weight Loss
Reed, J. L., Chaput, J., Tremblay, A., & Doucet, É. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.022 · Cited by 22
Paris, H. L. R., Foright, R. M., Werth, K., Larson, L. C., Beals, J. W., Cox‐York, K. A., Bell, C., & Melby, C. L. (2015) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2015.11.005 · Cited by 20
Shebanits, K., Andersson‐Assarsson, J. C., Larsson, I., Carlsson, L. M. S., Feuk, L., & Larhammar, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194668 · Cited by 22
“In a long-term study of hormonal levels after weight loss in adults [43], the level of satiety hormones was significantly decreased while the levels of hunger hormones increased significantly, as if trying to bring the individuals back to higher body weight.”
Exploring the wider benefits of semaglutide treatment in obesity: insight from the STEP program.
O’Neil, P. M., & Rubino, D. M. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2150006 · Cited by 19
“While some studies suggest that weight loss interventions can increase appetite, hunger, and craving [22,56], most suggest decreases in those phenomena with such interventions [56–58].”
Potential contributors to variation in weight‐loss response to liraglutide
Webster, C. M., Mittal, N., Dhurandhar, E. J., & Dhurandhar, N. V. (2023) · Obesity Reviews · doi:10.1111/obr.13568 · Cited by 19
“Furthermore, diet-induced weight loss can alter hormone levels to increase appetite.(2) For example, following weight loss, concentrations of the hunger hormone ghrelin rise, which may increase appetite, driving weight regain.”
BackgroundHansen, T. T., Hjorth, M. F., Sandby, K., Andersen, S. V., Astrup, A., Ritz, C., Bulló, M., Camacho-Barcía, M. L., García-Gavilán, J. F., Salas-Salvadó, J., et al. (2019) · British Journal of Nutrition · doi:10.1017/s0007114519001296 · Cited by 19
“Different factors motivating an individual to eat may be considered important in the control of eating behaviour (28) , and physiological regulators of appetite is found to be increased after a weight loss (29 – 31) .”
Rispal, J., Escaffit, F., & Trouche, D. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10055-0 · Cited by 21
“or GLP-1 by enteroendocrine cells; interestingly, these hormones remain expressed at a high level more than one year after the restriction diet [125].”
BackgroundManaging weight and glycaemic targets in people with type 2 diabetes—How far have we come?
Blüher, M., Ceriello, A., Davies, M., Rodbard, H., Sattar, N., Schnell, O., Tonchevska, E., & Giorgino, F. (2022) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.330 · Cited by 20
John, H. S., Doucet, É., & Power, K. A. (2023) · Obesity Reviews · doi:10.1111/obr.13598 · Cited by 22
“Diet-induced weight loss can further exacerbate any dysregulation of PYY and GLP-1 secretion in both fasted and postprandial states, and these alterations have shown to persist 1-year after weight loss in individuals that have maintained weight loss and in those that have gained a portion of the weight back.(61) Ghrel…”
BackgroundMartins, C., Roekenes, J. A., Rehfeld, J. F., Hunter, G. R., & Gower, B. A. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.10.010 · Cited by 21
Time Restricted Eating: A Valuable Alternative to Calorie Restriction for Addressing Obesity?
Parrotta, M. E., Colangeli, L., Scipione, V., Vitale, C., Sbraccia, P., & Guglielmi, V. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00609-z · Cited by 21
Pellitero, S., Pérez, N., Martínez-Cáceres, E. M., Granada, M. L., Moreno, P., Balibrea, J. M., Tarascó, J., Lucas, A., & Puig‐Domingo, M. (2015) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.08.040 · Cited by 21
Shedding pounds after going under the knife: Guts over glory—why diets fail
Larder, R., & O’Rahilly, S. (2012) · Nature Medicine · doi:10.1038/nm.2747 · Cited by 24
Maurer, L., Mai, K., Krude, H., Haynes, J., Weygandt, M., & Spranger, J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.014 · Cited by 21
“It seems that the modulation of the GLP-1 response during dietary intervention studies changes at a rather slow pace over several weeks to months [5,49].”
BackgroundFedonidis, C., Alexakis, N., Koliou, X., Asimaki, O., Tsirimonaki, E., & Mangoura, D. A. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.24 · Cited by 22
Genes and the hypothalamic control of metabolism in humans
Hinney, A., Volckmar, A., & Antel, J. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.04.007 · Cited by 23
Medical Management of Obesity: A Comprehensive Review
Grunvald, E. L. (2014) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000041 · Cited by 19
“For example, hormonal changes that promote appetite stimulation do not revert to baseline levels even after long-term sustainedweight reduction.(6) Likewise, there is evidence that metabolic efficiency increases after significant weight loss, a process termed adaptive thermogenesis, whereby an individual’s metabolic r…”
BackgroundInequalities in access to bariatric surgery in Canada
Sharma, A. M. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150697 · Cited by 20
Ebbeling, C. B., Klein, G. L., Luoto, P. K., Wong, J. M., Bielak, L., Eddy, R. G., Steltz, S. K., Devlin, C. A., Sandman, M., Hron, B. M., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.12.004 · Cited by 19
Huang, Y., Zheng, Q., Yang, H., Fu, X., Zhang, X., Xia, C., Zhu, Z., Liu, Y., & Liu, W. J. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4851671 · Cited by 19
Fasting diets: what are the impacts on eating behaviors, sleep, mood, and well-being?
Hosseini, E., Ammar, A., Josephson, J. K., Gibson, D. L., Askari, G., Bragazzi, N. L., Trabelsi, K., Schöllhorn, W. I., & Mokhtari, Z. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1256101 · Cited by 20
“A study by Sumithran et al. (45) indicated that greater weight loss ( ≥ 8”
BackgroundFostering Resilience and Wellness: The Synergy of Mindful Eating and the Mediterranean Lifestyle
Christodoulou, E., Deligiannidou, G.-E., Kontogiorgis, C. A., Giaginis, C., & Koutelidakis, A. Ε. (2024) · Applied Biosciences · doi:10.3390/applbiosci3010004 · Cited by 22
Zein, M. A., Akomolafe, A. F., Mahmood, F. R., Khrayzat, A., Sahebkar, A., Pintus, G., Kobeissy, F. H., & Eid, A. H. (2024) · Obesity Reviews · doi:10.1111/obr.13807 · Cited by 21
“125,126 In a study involving 10 women with obesity who reached a non-obese state (BMI 30 kg/m 2 ) after either bariatric surgery or lifestyle modification, weight loss was accompanied by reductions in fat cell volume, leptin secretion, and plasma leptin concentrations.”
Kumar, R. B., & Aronne, L. J. (2016) · Techniques in Gastrointestinal Endoscopy · doi:10.1016/j.tgie.2016.11.003 · Cited by 19
Long‐term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study
Tchang, B. G., Aras, M., Wu, A. H. B., Aronne, L. J., & Shukla, A. P. (2021) · Obesity Science & Practice · doi:10.1002/osp4.575 · Cited by 19
“Weight loss leads to a counterregulatory response manifesting as a reduction in energy expenditure(14) and central and peripheral hormonal changes that lead to increased hunger, decreased satiety and increased energy intake.(15) AOMs that target these neurohormonal adaptations may potentially blunt weight regain and f…”
BackgroundMehta, N. K. (2023) · Milbank Quarterly · doi:10.1111/1468-0009.12635 · Cited by 20
Young, M. D., Plotnikoff, R. C., Collins, C. E., Callister, R., & Morgan, P. J. (2015) · British Journal of Health Psychology · doi:10.1111/bjhp.12137 · Cited by 18
Adipositas-assoziierte Lymphödeme – unterschätzt und unterbehandelt
Bertsch, T. (2018) · Phlebologie · doi:10.12687/phleb2410-2-2018 · Cited by 18
The role of gut hormones in obesity
Mok, J., Makaronidis, J., & Batterham, R. L. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.09.005 · Cited by 20
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity
C, K. A. C. M. V. R. L. J. K. A. G. A. A. A. B. B. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005729 · Cited by 36
Recent progress in the pharmacotherapy for obesity
Lu, J., Liu, P., Cai, M., Lv, T., Zhang, M., Yin, K., Cheng, J., & Zhang, G. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177850 · Cited by 17
Flack, K. D., Anderson, R. E., McFee, K. F., Kryscio, R., & Rush, C. R. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113711 · Cited by 17
Edwards‐Hampton, S. A., & Ard, J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15819 · Cited by 17
“24,25 26 Despite the expected increase in hunger with reduced calorie intake, several studies have shown that MR used as part of a VLCD has been associated with reduced cravings, symptoms of hunger, and improved satiety during treatment.”
Karl, J. P., Berryman, C. E., Harris, M. N., Lieberman, H. R., Gadde, K. M., Rood, J. C., & Pasiakos, S. M. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa024 · Cited by 17
“Nonetheless, circulating total (acyl + des-acyl) ghrelin increases in response to energy deficit [23, 33], and may contribute to a drive to eat that promotes regain of TBM and FM [21].”
BackgroundShah, E., Al-Shiab, R., Abdo, A., Özbek, L., Covic, A. C., & Kanbay, M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70713 · Cited by 17
Hanson, P., Randeva, H. S., Cuthbertson, D. J., O'Hare, P. J., Parsons, N., Chatha, K. K., Reidy, G., Weickert, M. O., & Barber, T. M. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.381 · Cited by 17
Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction
Reddy, Y. N. V., Melenovský, V., Asokan, A. K., Haluzı́k, M., Carter, R. E., Nair, K. S., Jensen, M. D., & Borlaug, B. A. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae534 · Cited by 17
Behary, P., Cegla, J., Tan, T., & Bloom, S. R. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1048181 · Cited by 21
“Following weight loss through caloric restriction, levels of ghrelin are elevated, whereas levels of leptin, another anorectic hormone and PYY, are reduced [24].”
BackgroundIntra-abdominal fat accumulation is a hypertension risk factor in young adulthood
Takeoka, A., Tayama, J., Yamasaki, H., Kobayashi, M., Ogawa, S., Saigo, T., Kawano, H., Abiru, N., Hayashida, M., Maeda, T., et al. (2016) · Medicine · doi:10.1097/md.0000000000005361 · Cited by 17
“This phenomenon is caused by crosstalk between adipose tissue and the central nervous system with adipokines such as leptin and ghrelin.([38]) Thus, an effective weight-reduction program should take into account these mechanisms.”
Casanova, N., Finlayson, G., Blundell, J. E., & Hopkins, M. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.06.007 · Cited by 18
“adaptive thermogenesis((7)), and increased muscular efficiency((8)), appetite((9)) and EI((10)).”
BackgroundStubbs, R. J., Duarte, C., O’Driscoll, R., Turicchi, J., & Michałowska, J. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119001083 · Cited by 17
“Reports of changes in peripheral appetite peptides in response to 10–20 % WL produce results that can be interpreted as being consistent with WL increasing homeostatic increases in appetite((43,44,47,49,50)).”
BackgroundLodi, A., Zarantonello, L., Bisiacchi, P. S., Cenci, L., & Paoli, A. (2020) · Obesity · doi:10.1002/oby.22934 · Cited by 19
“392) (Figure 3B) as well as dividing them by the type of diet followed (MD group, r[15] = −0.”
MethodPractical Approaches to Treating Obesity: Patient and Healthcare Professional Perspectives
O'Shea, D. B., Kahan, S. I., Lennon, L., & Breen, C. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01748-0 · Cited by 19
“Weight loss is associated with marked and persistent alterations in the levels of hormones involved in the regulation of satiety [6].”
BackgroundFuller, N. R., Lau, N. S., Denyer, G. S., & Caterson, I. D. (2013) · Clinical Obesity · doi:10.1111/cob.12030 · Cited by 20
“Percentage changes in weight in that very low energy diet study (7) were −14% at week 10 and −8.”
BackgroundResultInfluentialSustained hunger suppression from stable liquid food foams
Melnikov, S. M., Stoyanov, S. D., Kovacs, E. M. R., Arnaudov, L. N., de Groot, P. W. N., Schuring, E. A. H., Wiseman, S. A., Mela, D. J., & Peters, H. P. F. (2014) · Obesity · doi:10.1002/oby.20828 · Cited by 19
“During periods of negative energy balance, a number of physiological factors tend to counteract attempts to sustain a reduced energy intake (4,5), and measures of perceived hunger are inversely related to “ease” and outcomes in weight loss trials (6-8).”
BackgroundTeegala, S. B., Sheng, Z., Dalal, M. S., Hirschberg, P. R., Beck, K. D., & Routh, V. H. (2018) · Brain Research · doi:10.1016/j.brainres.2018.05.025 · Cited by 19
Franz, M. J., & MacLeod, J. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s141952 · Cited by 21
Implications of the Developmental Origins of Health and Disease concept for policy-making
Jacob, C. M., & Hanson, M. A. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.08.001 · Cited by 18
Scragg, J., Koutoukidis, D. A., Dirksen, C., Heitmann, B. L., & Jebb, S. A. (2025) · Med · doi:10.1016/j.medj.2025.100805 · Cited by 16
Zhu, R., Fogelholm, M., Larsen, T. M., Poppitt, S. D., Silvestre, M. P., Vestentoft, P. S., Jalo, E., Navas-Carretero, S., Huttunen-Lenz, M., Taylor, M. A., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.685648 · Cited by 16
“Desire to eat something 32 (10, 60) 59 (35, 79) 61 (40, 80) 55 (34, 78)”
BackgroundGPR84 in physiology—Many functions in many tissues
Aktar, R., Rondinelli, S., & Peiris, M. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16206 · Cited by 19
Ketogenic diet and behavior: insights from experimental studies
Grabowska, K., Grabowski, M., Przybyła, M., Pondel, N., Barski, J. J., Nowacka-Chmielewska, M. M., & Liśkiewicz, D. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1322509 · Cited by 18
“Increased feeling of hunger is a common side effect of diet-induced weight loss that in the long term leads to reduced patient adherence compromising the results of the therapy and finally promoting weight regain (131, 132).”
BackgroundMetabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m2: A Surgeon’s Perspective
COHEN, R. V., Caravatto, P. P. D. P., & Petry, T. B. Z. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0930-2 · Cited by 17
Ogata, K., Koyama, K. I., Amitani, M. S., Amitani, H., Asakawa, A., & Inui, A. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00056 · Cited by 22
“In addition, while rebound weight gain is commonly observed in the first year following initial weight loss, all of the participants in the current study achieved further weight loss during the 18-month follow-up period (22).”
BackgroundGrannell, A., Fallon, F., Pournaras, D. J., & le Roux, C. W. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02319-y · Cited by 18
Activation of ventral tegmental area neurotensin Receptor-1 neurons promotes weight loss
Perez‐Bonilla, P., Santiago-Colon, K., Matasovsky, J., Ramirez‐Virella, J., Khan, R., Garver, H. S., Fink, G. D., Dorrance, A. M., & Leinninger, G. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108639 · Cited by 18
Imaging individuals with obesity
Nabasenja, C., Barry, K., Nelson, T., Chandler, A., & Hewis, J. (2022) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2022.02.003 · Cited by 18
Hajipoor, S., Hekmatdoost, A., Pasdar, Y., Mohammadi, R., Alipour, M., Rezaie, M., Nachvak, S. M., Balthazar, C. F., Sobhiyeh, M. R., Mortazavian, A. M., et al. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.2816 · Cited by 19
“Our result is inconsistent with previous research demonstrating the effect of negative energy balance on gut peptides (Pasiakos et al., 2012; Sumithran et al., 2011).”
ResultFasting gut hormone levels change with modest weight loss in obese adolescents
Jensen, D. E., Nguo, K., Baxter, K. A., Cardinal, J. W., King, N. A., Ware, R. S., Truby, H., & Batch, J. (2015) · Pediatric Obesity · doi:10.1111/ijpo.275 · Cited by 16
Requested meals versus scheduled meals
Ciampolini, M. (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s29889 · Cited by 20
“Contrasting high mean blood glucose as well as overt and hidden overweight requires long-term strategies to prevent relapse.(22,23) Factors responsible included sweetened beverages, low intake of vegetables and fruits, limited physical activity, and use of alcohol.”
BackgroundHarveian Oration 2016: Some observations on the causes and consequences of obesity
O’Rahilly, S. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-6-551 · Cited by 18
Obesity: Are shared medical appointments part of the answer?
Shibuya, K., Pantalone, K. M., & Burguera, B. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.18006 · Cited by 15
Grannell, A., le Roux, C. W., & McGillicuddy, D. (2021) · Qualitative Health Research · doi:10.1177/10497323211040767 · Cited by 17
“This is a phenomenon expected in response to starvation yet occurs in response to weight loss for many PWO and is likely a strong determinant of weight regain (Sumithran et al., 2011).”
The impact of weight loss among seniors on Medicare spending
Thorpe, K. E., Yang, Z., Long, K. M., & Garvey, W. T. (2013) · Health Economics Review · doi:10.1186/2191-1991-3-7 · Cited by 16
“Recent evidence suggests physiologic mediators are responsible for the weight re-gain that often follows weight loss induced by lifestyle modification [9].”
BackgroundTham, M., Chong, T. W. H., Jenkins, Z. M., & Castle, D. J. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.11.002 · Cited by 15
Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations
Husein, N., & Chetty, A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.016 · Cited by 15
Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity
Gudzune, K. A., Apovian, C. M., Aroda, V. R., Aronne, L. J., Balapattabi, K., Bennett, A. K., ChallaSivaKanaka, S., ElSayed, N. A., Fitch, A., Fitzpatrick, S. L., et al. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doci25-0008 · Cited by 27
“Weight reduction also negatively affects energy expenditure and basal metabolic rate, which makes weight loss maintenance challenging for individuals with obesity (10,11).”
Buso, M. E. C., Seimon, R. V., McClintock, S., Muirhead, R., Atkinson, F. S., Brodie, S., Dodds, J., Zibellini, J., Das, A., Wild-Taylor, A. L., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.640538 · Cited by 17
Chen, H., Zhou, T., Wu, S., Cao, Y., Zong, G., & Yuan, C. (2023) · BMC Medicine · doi:10.1186/s12916-022-02674-w · Cited by 17
“For example, BPV and PRV were associated with poor cardiac and vascular regulation [60, 61], and BWV was linked to adipose tissue inflammation [62] and adipokine secretion alteration [63, 64].”
BackgroundMartins, C., Nymo, S., Coutinho, S. R., Rehfeld, J. F., Hunter, G. R., & Gower, B. A. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.03.026 · Cited by 15
Tabei, S., Chamorro, R., Meyhöfer, S. M., & Wilms, B. (2024) · Biomedicines · doi:10.3390/biomedicines12030537 · Cited by 19
“Long-term maintenance of weight loss is difficult and may ultimately lead to weight gain after an initial phase of weight loss [3,4].”
BackgroundFarhadnejad, H., Saber, N., Tehrani, A. N., Jahromi, M. K., Mokhtari, E., Norouzzadeh, M., Teymoori, F., Asghari, G., Mirmiran, P., & Azizi, F. (2024) · Journal of Nutrition and Metabolism · doi:10.1155/2024/8300428 · Cited by 21
“Safron extracts can also decrease malondialdehyde levels, a marker of lipid peroxidation caused by reactive oxygen species [80–82].”
BackgroundLundanes, J., Storliløkken, G. E., Solem, M. S., Dankel, S. N., Tangvik, R. J., Ødegård, R. A., Holst, J. J., Rehfeld, J. F., Martins, C., & Nymo, S. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.11.018 · Cited by 18
Jeromson, S., Baranowski, B., Akcan, M., Waters, B. D., Eisner, K., Bellucci, A., Trang, S., Abolhassani, A., Tello‐Palencia, M. A., Schweitzer, A. M., et al. (2025) · The Journal of Physiology · doi:10.1113/jp289449 · Cited by 23
Moritz, S., Göritz, A. S., Schmotz, S., Weierstall‐Pust, R., Gehlenborg, J., Gallinat, J., & Kühn, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0655-7 · Cited by 15
Sawami, K., Tanaka, A., & Node, K. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01611-8 · Cited by 15
“Since endocrinological changes such as changes to leptin, ghrelin, and GIP levels that promote weight regain persist long after weight loss [10], patients with obesity regain weight after one year of lifestyle modification.”
BackgroundThe inflammatory proteome, obesity, and medical weight loss and regain in humans
Perry, A., Tanrıverdi, K., Risitano, A., Hwang, S., Murthy, V. L., Nayor, M. G., Zhao, S., Levy, D. A., Shah, R. V., & Freedman, J. E. (2022) · Obesity · doi:10.1002/oby.23587 · Cited by 16
“Beyond resting metabolic rate, however, propensity to regain weight appears multifactorial, including regulation of appetite [31,32], interindividual differences in substrate utilization [33], alteration in adaptive thermogenesis with weight loss [15,34], and individual lifestyle factors in an “obesogenic” environment…”
Background
Metadata
- Authors
- Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J.
- Affiliations
- The University of Melbourne (AU)
- La Trobe University (AU)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-10-27
- Volume
- 365
- Issue
- 17
- Pages
- 1597-1604
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2167222546
- Semantic Scholar
- 3a76a35458f699a743f3d47b276f2fea2ca1d1c0
- Cited by
- 1,449
- References
- 39
- Citations by year
- 2026: 128 · 2025: 98 · 2024: 97 · 2023: 99 · 2022: 104 · 2021: 109 · 2020: 104 · 2019: 92 · 2018: 101 · 2017: 101 · 2016: 86 · 2015: 79 · 2014: 78 · 2013: 95 · 2012: 75
- FWCI
- 37.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- weight loss, hormonal adaptation, appetite, leptin, ghrelin, peptide YY, cholecystokinin, glucose-dependent insulinotropic polypeptide, pancreatic polypeptide, amylin, glucagon-like peptide-1, insulin, very low calorie diet, weight regain
- MeSH terms
- Body Weight, Cholecystokinin, Diet, Reducing, Female, Gastrointestinal Hormones, Humans, Male, Middle Aged, Obesity, Peptides, Weight Loss, Body Mass Index, Postmenopause, Peptide YY, Leptin, Glucagon-Like Peptide 1, Ghrelin, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.